However, retatrutide lacks the long-term safety data that tirzepatide has accumulated, and it is not yet FDA-approved for any indication
Have you ever wished your muscles bounced back faster after a big session
Critical considerations for bodybuilders Muscle loss: GLP-1-class compounds can cause muscle loss if sufficient protein is not consumed (~2 g per kg body weight) and resistance training is not performed
Declaration of Generative AI and AI-assisted technologies in the writing process The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI
Pan L, Wang H, Gu K (2018) Nanoliposomes as vehicles for astaxanthin: characterization, in vitro release evaluation and structure
Retatrutide is a next-generation triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, making it one of the most studied compounds in modern metabolic peptide research
.webp)
